234 related articles for article (PubMed ID: 26078255)
1. Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.
Kovatchev B; Umpierrez G; DiGenio A; Zhou R; Inzucchi SE
J Diabetes Sci Technol; 2015 Jun; 9(6):1227-35. PubMed ID: 26078255
[TBL] [Abstract][Full Text] [Related]
2. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
Diabetes Res Clin Pract; 2015 Apr; 108(1):179-86. PubMed ID: 25661664
[TBL] [Abstract][Full Text] [Related]
3. Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.
Umpierrez GE; O'Neal D; DiGenio A; Goldenberg R; Hernandez-Triana E; Lin J; Park CY; Renard E; Kovatchev B
Diabetes Obes Metab; 2017 Sep; 19(9):1317-1321. PubMed ID: 28256054
[TBL] [Abstract][Full Text] [Related]
4. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
Diabetes Res Clin Pract; 2015 Nov; 110(2):234-40. PubMed ID: 27049155
[TBL] [Abstract][Full Text] [Related]
5. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
Guelho D; Paiva I; Batista C; Barros L; Carrilho F
Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
[TBL] [Abstract][Full Text] [Related]
6. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
[TBL] [Abstract][Full Text] [Related]
7. Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus.
Peña NV; Torres M; Cardona JA; Iniesta R
Diabetes Technol Ther; 2013 Feb; 15(2):136-42. PubMed ID: 23289433
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia and blood glucose fluctuations in the application of a sensor-augmented insulin pump.
Luo P; Cheng Q; Chen B; Li Y; Wu J; Zhang X; Jiao X; Zhao J; Lv X
Diabetes Technol Ther; 2013 Dec; 15(12):984-9. PubMed ID: 24004044
[TBL] [Abstract][Full Text] [Related]
9. Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes.
Levin PA; Zhou S; Gill J; Wei W
J Manag Care Spec Pharm; 2015 Dec; 21(12):1172-81. PubMed ID: 26679966
[TBL] [Abstract][Full Text] [Related]
10. The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes.
Alghothani N; Dungan KM
Diabetes Technol Ther; 2011 Nov; 13(11):1085-9. PubMed ID: 21770764
[TBL] [Abstract][Full Text] [Related]
11. Relationships among different glycemic variability indices obtained by continuous glucose monitoring.
Saisho Y; Tanaka C; Tanaka K; Roberts R; Abe T; Tanaka M; Meguro S; Irie J; Kawai T; Itoh H
Prim Care Diabetes; 2015 Aug; 9(4):290-6. PubMed ID: 25456706
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
[TBL] [Abstract][Full Text] [Related]
13. The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice.
Muñoz OM; Gómez AM; Maira GJ; Fabián Mauricio LV; Ruiz-Morales ÁJ
Diabetes Metab Syndr; 2018 Jul; 12(4):555-561. PubMed ID: 29631779
[TBL] [Abstract][Full Text] [Related]
14. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
15. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
Crenier L
Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
[TBL] [Abstract][Full Text] [Related]
16. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
17. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
[TBL] [Abstract][Full Text] [Related]
18. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
19. Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data.
Qu Y; Jacober SJ; Zhang Q; Wolka LL; DeVries JH
Diabetes Technol Ther; 2012 Nov; 14(11):1008-12. PubMed ID: 23101951
[TBL] [Abstract][Full Text] [Related]
20. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
